Tag results:

lymphoid cells

The Healthy Exocrine Pancreas Contains Preproinsulin-Specific CD8 T Cells That Attack Islets in Type 1 Diabetes

[Science Advances] The authors quantified preproinsulin-specific CD8+ T cells within different areas of the human pancreas from nondiabetic controls, autoantibody-positive donors, and donors with type 1 diabetes to investigate their role in diabetes development.

Lactobacillus rhamnosus and Bifidobacterium longum Alleviate Colitis and Cognitive Impairment in Mice by Regulating IFN-γ to IL-10 and TNF-α to IL-10 Expression Ratios

[Scientific Reports] Intraperitoneal injection of lipopolysaccharide and oral gavage of ampicillin increased IFN-γ and TNF-α expression in the spleen, colon, and hippocampus, while IL-10 expression decreased.

The Immunology of Asymptomatic SARS-CoV-2 Infection: What Are the Key Questions?

[Nature Reviews Immunology] An important challenge during the COVID-19 pandemic has been to understand asymptomatic disease and the extent to which this may be a source of transmission. Areas that need greater clarity include the extent to which asymptomatic disease leads to persistent symptoms, and the quality, quantity and durability of immune priming required to confer subsequent protection.

Dysregulation of TFH-B-TRM Lymphocyte Cooperation Is Associated with Unfavorable Anti-PD-1 Responses in EGFR-Mutant Lung Cancer

[Nature Communications] Hypothesizing that EGFR mutations alter tumor-immune interactions, scientists compared tumor-infiltrating lymphocytes between EGFR mutant and wild type tumors through single-cell transcriptomic analysis.

Single-Cell RNA Sequencing Reveals Distinct Tumor Microenvironmental Patterns in Lung Adenocarcinoma

[Oncogene] To identify clinically relevant microenvironmental and cancer features, scientists applied single-cell RNA sequencing to ten human lung adenocarcinomas and ten normal control tissues.

The Emerging Role of Off-the-Shelf Engineered Natural Killer Cells in Targeted Cancer Immunotherapy

[Molecular Therapy-Oncolytics] CAR-engineered natural killer (NK)-92 cells have demonstrated robust antitumor activity in in vitro and in vivo preclinical studies, propelling the clinical development of CAR NK-92 cells.

Popular